GLENN L. COOPER

Corporate Board Profile

Tech Score: 0/100

REPLIGEN CORP

Filing Date	Source Excerpt
2012-04-20	Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009. Mr. Cooper served as the Chairman and Chief Executive Officer of Indevus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on urology and endocrinology... Mr. Cooper’s qualifications to sit on the Board of Directors include his leadership roles at pharmaceutical companies and his expertise in the clinical and regulatory areas.
2013-04-09	Mr. Cooper received an M.D. from Tufts University School of Medicine, performed his postdoctoral training in Internal Medicine and Infectious Diseases at the New England Deaconess Hospital and the Massachusetts General Hospital and received a B.A. from Harvard College.

Filing Date

Source Excerpt

2012-04-20

Glenn L. Cooper, M.D. has served as a Director of Repligen since August 2009. Mr. Cooper served as the Chairman and Chief Executive Officer of Indevus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on urology and endocrinology... Mr. Cooper’s qualifications to sit on the Board of Directors include his leadership roles at pharmaceutical companies and his expertise in the clinical and regulatory areas.

2013-04-09

Mr. Cooper received an M.D. from Tufts University School of Medicine, performed his postdoctoral training in Internal Medicine and Infectious Diseases at the New England Deaconess Hospital and the Massachusetts General Hospital and received a B.A. from Harvard College.

Data sourced from SEC filings. Last updated: 2025-07-01